Stock comparison
IDEXX Laboratories
Merit Medical Systems
Scored across Buffett, Graham, Lynch and Greenblatt - plus a side-by-side metric table covering valuation, quality, growth and balance sheet.
IDXX
IDEXX Laboratories
Market cap
$44.12B
Sector
Healthcare
MMSI
Merit Medical Systems
Market cap
$3.83B
Sector
Healthcare
Overall winner
IDEXX Laboratories IDXX
Wins on the combined sum of fit scores across all four strategies. Per-strategy breakdown below.
Fit scores by strategy
| Strategy | IDXX | MMSI | Winner |
|---|---|---|---|
| Warren Buffett | 75B | 58D | IDXX |
| Benjamin Graham | 80A | 73B | IDXX |
| Philip Fisher | 75B | 59C | IDXX |
| Peter Lynch | 71B | 52C | IDXX |
| Joel Greenblatt | 83C | 39D | IDXX |
| Charlie Munger | 87A | 45D | IDXX |
| Terry Smith | 84A | 49D | IDXX |
Side-by-side metrics
| Metric | IDXX | MMSI |
|---|---|---|
| Market cap | $44.12B | $3.83B |
| P/E (TTM) | 39.0x | 27.0x |
| EV/EBIT | 31.6x | 22.2x |
| ROIC (TTM) | 40.66% | 5.56% |
| Gross margin | 62.05% | 48.65% |
| Net margin | 24.63% | 9.03% |
| Revenue CAGR 5y | 7.56% | 8.96% |
| EPS CAGR 5y | 10.79% | 26.03% |
| Debt / Equity | 0.7x | 0.5x |
| Dividend yield | 0.0% | 0.0% |
Where each one wins
The metrics with the biggest gap between the two - sorted so the most decisive edges read first.
IDXX leads on
- Market cap$44.12Bvs $3.83B+91%
- ROIC (TTM)40.66%vs 5.56%+86%
- Net margin24.63%vs 9.03%+63%
- Gross margin62.05%vs 48.65%+22%
MMSI leads on
- EPS CAGR 5y26.03%vs 10.79%+59%
- P/E (TTM)27.0xvs 39.0x+31%
- EV/EBIT22.2xvs 31.6x+30%
- Debt / Equity0.5xvs 0.7x+27%
Related on invest-like
Key terms in this analysis
Educational tool. Fit scores are deterministic projections from public financials onto each investor's published criteria - not personal recommendations or advice.